Model and tech spotlights

Manuscript  -  1 February 2024

Novel technique for preclinical assessment of targeted therapies to inhibit both primary and metastatic non-small cell lung cancer

Manuscript  -  1 February 2024

BxPC-3: Evaluating responses to standard therapeutic agents in subcutaneous mouse model of human pancreatic cancer

Manuscript  -  1 August 2022

Exploring orthotopic glioblastoma models to treat tumors and strengthen immune responses in the brain

Manuscript  -  1 August 2022

Plate-based 3D culture assays that mimic the tumor microenvironment and predict in vivo responses

Manuscript  -  1 July 2018

Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation

Manuscript  -  1 June 2018

E0771 syngeneic breast cancer model

Manuscript  -  1 November 2017

ID8: A syngeneic mouse model for testing ovarian cancer immunotherapies

Manuscript  -  1 October 2017

A20: Modeling B cell lymphoma in mice

Manuscript  -  1 December 2016

4T1-luc2: An orthotopic mammary cancer model to support novel immuno-oncology drug discovery

Manuscript  -  1 May 2016

A549 – A model for non-small cell lung cancer

Manuscript  -  1 February 2016

CT26: Murine colon carcinoma